MEDICLIN Aktiengesellschaft reported a significant financial improvement for the first nine months of 2025, with group operating results climbing to €48.9 million from €34.5 million in the same period last year, a 42% increase. Consolidated group sales reached €586.9 million, up €28.7 million or 5.1% from the previous year's €558.2 million. Overall capacity utilization remained stable at 86.8% across the group's facilities.
The post-acute segment emerged as the strongest performer, with sales increasing by 9.3% to €394.6 million and segment operating result rising by €9.6 million to €47.6 million. The cost of materials ratio in this segment improved, falling by 0.9 percentage points to 19.5%, though total cost of materials increased by 4.4% to €77.0 million. Personnel expenses in the post-acute segment grew by €17.6 million or 9.4% to €205.0 million, primarily due to salary increases and higher employee numbers, though the personnel expense ratio remained unchanged at 51.9%.
In the acute segment, strategic changes including the sale of the former MEDICLIN Herzzentrum Coswig influenced performance, with segment sales decreasing by €5.7 million or 3.2%. However, the segment showed remarkable operational improvement, with operating result turning positive at €0.7 million compared to a loss of €3.8 million in the same period last year, a 117.2% improvement. Cost management showed positive trends with cost of materials falling by 4.8% to €47.6 million and personnel expenses decreasing by 4.8% to €101.0 million.
The nursing care segment reported sales of €18.6 million but experienced a segment operating result of -€0.4 million, down €0.5 million from the previous year. Meanwhile, the service segment showed positive momentum with sales increasing by €3.3 million to €74.8 million and segment operating result improving by €0.8 million to €1.0 million.
The Management Board confirmed its guidance for the full 2025 financial year, expecting consolidated group sales growth between 2.0% and 5.0% and consolidated group EBIT between €53.0 million and €64.0 million. Tino Fritz, CFO of MEDICLIN, commented that given current conditions and typical seasonal effects in the fourth quarter, the company continues to assess business development as solid.
For HR vendors, MEDICLIN's performance highlights the growing demand for post-acute care services, which may influence workforce planning and staffing needs. The company's focus on cost management and operational efficiency, particularly in the acute segment, underscores the importance of talent management solutions that optimize labor costs and improve productivity. The stable capacity utilization suggests consistent patient volumes, driving need for skilled healthcare workers. MEDICLIN, part of the Asklepios Group, operates 31 clinics, six care facilities, and nine medical care centers with approximately 8,200 beds and care places, employing around 9,900 people across its network. The interim report as of September 30, 2025, is available at https://www.mediclin.de.
